All posts in
BMS Offers €850M for a British Oncolytic Virus better than CAR-T
Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis
Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials
Green Light from the FDA for a Swedish Therapy targeting All Solid Tumors
What do the CAR-T Patient Deaths Mean for the Future of the Field?
The Munich Biotech Mafia expand to the US with a New TCR Startup
Investors bid on Nordic Nanovector’s Hottest Cancer Antibodies
Sanofi Jumps into the Biosimilars Market aiming for Asia
How is European Immuno-Oncology fighting Blood Cancer?
Another Pharma sloughs off Small Molecules to focus on Biologics
Video: Chatting with Immunocore about the Potential of Immuno-oncology
Better than ADCs? AstraZeneca bids for Bicyclic Peptides
Labiotech UG, All Rights Reserved -
Send this to friend